CID 146000545

N-[(5s)-6-[2-[[2-[(2s,4r)-2-[[(2s)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]carbamoyl]-4-carbamimidamidopyrrolidin-1-yl]-2-oxoethyl]-[2-(2-amino-6-oxo-1h-purin-9-yl)acetyl]amino]ethylamino]-5-[[(2s)-2,6-bis[[(2s,4s)-4-amino-1-[2-[2-[[2-[2-aminoethyl-[2-(2-amino-6-oxo-1h-purin-9-yl)acetyl]amino]acetyl]amino]ethyl-[2-(2-amino-6-oxo-1h-purin-9-yl)acetyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-6-oxohexyl]pyrazine-2-carboxamide

Structural Information

Molecular Formula
C97H129N51O23
SMILES
C1[C@@H](CN([C@@H]1C(=O)NCCCC[C@@H](C(=O)N[C@@H](CCCCNC(=O)C2=NC=CN=C2)C(=O)NCCN(CC(=O)N3C[C@@H](C[C@H]3C(=O)N[C@@H](CC4=CC=C(C=C4)O)C(=O)N)NC(=N)N)C(=O)CN5C=NC6=C5N=C(NC6=O)N)NC(=O)[C@@H]7C[C@@H](CN7C(=O)CN(CCNC(=O)CN(CCN)C(=O)CN8C=NC9=C8N=C(NC9=O)N)C(=O)CN1C=NC2=C1N=C(NC2=O)N)N)C(=O)CN(CCNC(=O)CN(CCN)C(=O)CN1C=NC2=C1N=C(NC2=O)N)C(=O)CN1C=NC2=C1N=C(NC2=O)N)N
InChI
InChI=1S/C97H129N51O23/c98-11-20-136(62(152)35-141-43-117-70-76(141)126-93(105)131-87(70)167)33-60(150)112-17-22-138(64(154)37-143-45-119-72-78(143)128-95(107)133-89(72)169)40-67(157)146-30-49(100)26-57(146)84(164)115-14-4-2-6-54(124-85(165)58-27-50(101)31-147(58)68(158)41-139(65(155)38-144-46-120-73-79(144)129-96(108)134-90(73)170)23-18-113-61(151)34-137(21-12-99)63(153)36-142-44-118-71-77(142)127-94(106)132-88(71)168)83(163)123-53(5-1-3-13-114-82(162)56-29-110-15-16-111-56)81(161)116-19-24-140(66(156)39-145-47-121-74-80(145)130-97(109)135-91(74)171)42-69(159)148-32-51(122-92(103)104)28-59(148)86(166)125-55(75(102)160)25-48-7-9-52(149)10-8-48/h7-10,15-16,29,43-47,49-51,53-55,57-59,149H,1-6,11-14,17-28,30-42,98-101H2,(H2,102,160)(H,112,150)(H,113,151)(H,114,162)(H,115,164)(H,116,161)(H,123,163)(H,124,165)(H,125,166)(H4,103,104,122)(H3,105,126,131,167)(H3,106,127,132,168)(H3,107,128,133,169)(H3,108,129,134,170)(H3,109,130,135,171)/t49-,50-,51+,53-,54-,55-,57-,58-,59-/m0/s1
InChIKey
FYDRBSNZQMOXLF-SABGPYMJSA-N
Compound name
N-[(5S)-6-[2-[[2-[(2S,4R)-2-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]carbamoyl]-4-carbamimidamidopyrrolidin-1-yl]-2-oxoethyl]-[2-(2-amino-6-oxo-1H-purin-9-yl)acetyl]amino]ethylamino]-5-[[(2S)-2,6-bis[[(2S,4S)-4-amino-1-[2-[2-[[2-[2-aminoethyl-[2-(2-amino-6-oxo-1H-purin-9-yl)acetyl]amino]acetyl]amino]ethyl-[2-(2-amino-6-oxo-1H-purin-9-yl)acetyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-6-oxohexyl]pyrazine-2-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

2376.0493 Da
Monoisotopic Mass

-16.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2377.0566 277.1
[M+Na]+ 2399.0385 273.3
[M-H]- 2375.0420 272.4
[M+NH4]+ 2394.0831 273.4
[M+K]+ 2415.0125 273.5
[M+H-H2O]+ 2359.0466 265.7
[M+HCOO]- 2421.0475 272.2
[M+CH3COO]- 2435.0632 272.4
[M+Na-2H]- 2397.0240 291.2
[M]+ 2376.0488 267.4
[M]- 2376.0498 267.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.